Fig. 3.

Study-specific delays in breast cancer: (A) from symptom recognition by the patient to her presentation to the first health care provider; (B) from presentation to breast cancer diagnosis or start of cancer treatment; and (C) from symptom recognition to diagnosis or start of treatment. ^aStudy eligibility restricted to advanced BC. See Table 2 for more detailed information on study-specific estimates of delay. A dashed line indicates that the delay estimate shown in the figure is an underestimation of the median value (the latter could not be calculated from the data provided in the original article). No delay estimates for Otieno et al. [22] are shown because average time from symptoms to diagnosis could not be estimated (>3 months for 73% of patients—all with advanced BC—with no further information provided; see Table 1, Table 2). BC = breast cancer; HCP = health care provider; IQR = interquartile range; Md = median; Me = mean; SSA = sub-Saharan Africa; wMe = weighted mean.